RAINBOW2023-04-012023-06-30 RAINBOW2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member RAINBOW2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member RAINBOW2023-04-012023-06-30in-bse-fin:OneOperatingExpenses03Member RAINBOW2023-04-012023-06-30in-bse-fin:OneOperatingExpenses04Member RAINBOW2023-04-012023-06-30in-bse-fin:OneOperatingExpenses05Member RAINBOW2023-04-012023-06-30in-bse-fin:OneOperatingExpenses06Member RAINBOW2023-04-012023-06-30in-bse-fin:OneOperatingExpenses07Member RAINBOW2023-04-012023-06-30in-bse-fin:OneOperatingExpenses08Member RAINBOW2023-04-012023-06-30in-bse-fin:OneOperatingExpenses09Member RAINBOW2023-04-012023-06-30in-bse-fin:OneOperatingExpenses10Member RAINBOW2023-06-30 RAINBOW2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543524 RAINBOW NOTLISTED Rainbow Childrens Medicare Limited Equity 2023-04-01 2024-03-31 2023-08-07 2023-07-31 INR Millions First quarter 13:40:00 15:35:00 2023-08-07 2023-08-07 Not applicable Single segment The business of running multi-specialty pediatric and obstetrics and gynecology hospital. 2023-04-01 2023-06-30 Unaudited Consolidated 2871650000.00 78550000.00 2950200000.00 383990000.00 0.00 0.00 435970000.00 146070000.00 253280000.00 1174650000.00 2393960000.00 556240000.00 0.00 556240000.00 156800000.00 -15460000.00 141340000.00 0.00 414900000.00 0.00 0.00 0.00 0.00 414900000.00 920000.00 415820000.00 409950000.00 4950000.00 410866000.00 4954000.00 1015020000.00 10 4.04 4.04 0.00 0.00 4.04 4.04 0.00 0.00 0.00 1.The above statement of unaudited consolidated financial results of Rainbow Children's Medicare Limited ( the Company ), and its subsidiaries (the Company and its subsidiaries together referred to as the Group ) which have been prepared in accordance with Indian Accounting Standards ( Ind AS ) prescribed under section 133 of Companies Act, 2013 ( the Act ) read with relevant rules issued thereunder, other accounting principles generally accepted in India and in terms of Regulation 33 of Securities and Exchange Board of India ( SEBI ) (Listing Obligations and Disclosure Requirements) Regulations, 2015 were reviewed and recommended by Audit Committee and approved by the Board of Directors at their respective meetings held on 7 August 2023. The Statutory Auditors have carried out a limited review on the unaudited consolidated financial results and issued an unmodified report thereon. 2.The consolidated figures for the quarter ended 31 March 2023 represent the difference between the published audited figures for the year ended 31 March 2023 and the published unaudied figures for the nine months period ended 31 December 2022, which was subject to limited review. 3.Final dividend for the financial year 2022-23 of Rs. 3 per Equity Share of Rs. 10 each aggregating to Rs. 304.51 million was approved by the shareholders at the 25th Annual General Meeting held on 29 June 2023 and the same was paid on 04 July 2023. 4. For point no. 4: Please Refer PDF Results 5.Pursuant to the resolutions passed by the Board on 18 March 2023 and by the Shareholders on 06 May 2023, the Company approved ‘Rainbow Children's Medicare Limited - Employee Stock Unit Plan 2023 (“Stock Unit Plan 2023”) in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 ( SEBI SBEB SE Regulations ). The Stock Unit Plan 2023 is for issue of employee stock units to eligible employees, which may result in an issuance of a maximum number of 400,000 Equity Shares. Upon exercise and payment of the exercise price, an option holder will be entitled to be allotted one Equity Share per employee stock unit. Upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company in their meeting held on 14 May 2023 and 07 August 2023, granted 275,000 and 37,414 Stock Units respectively under the Stock Unit Plan 2023 to its eligible employees which shall be exercisable into 312,414 equity shares having face value of Rs.10 each fully paid-up. The exercise price per stock unit shall be the face value of equity shares of the Company i.e., Rs.10 each. The vested Stock Units shall be exercisable within a period of 3 months from the date of each vesting. The Stock Units shall vest after the minimum vesting period of 1 year and not later than the maximum period of 5 years from the date of grant. The plan is in terms of SEBI SBEB SE Regulations. 6.During the financial year 2022-23, the Company won the bid for 2 land parcels in Gurugram, Haryana admeasuring 9,391 Sq. Mtr. ~ 2.32 acres and 4,987.10 Sq. Mtr. ~ 1.23 acres, situated in Sector 44 and Sector 56 respectively auctioned by Haryana Shahari Vikas Pradhikaran (HSVP). On 05 July 2023, the Company has received the allotment letters from HSVP, for the allotment of said land parcels to the Company post payment of full consideration of Rs. 1,299.40 million and Rs. 290.40 million for land parcles situated in Sector 44 and Sector 56 respectively. For point No. 7, 8 & 9 - Please refer PDF results Canteen expenses 51800000.00 Contract wages 75140000.00 Hospital maintenance 14660000.00 Housekeeping expenses 18840000.00 Lab and investigations 28300000.00 Other Expenses 116550000.00 Power and fuel 70930000.00 Professional fees to doctors 698390000.00 Rates and taxes 31660000.00 Repairs and maintenance 68380000.00 Re-measurement gain on defined benefit plans 1230000.00 1230000.00 310000.00 0.00